Drugs / GSL alpha-Gal
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00668512 | Mar 2007 → Mar 2014 | metastatic melanoma | University of Massachusetts, Worcester | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSL alpha-Gal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00668512 ↗ |
| Route | Other | “injected into a melanoma metastasis” NCT00668512 ↗ |